Market Overview

19
Articles
19K
Views

Author Profile

Timothy Monforton

 

02/25/2013 - 11:49am
With the 85th annual Academy Awards (now rebranded "The Oscars") in the books, it might be right to raise the question: Is the awards show still relevant? In terms of actual viewership figures, the Academy Awards ceremony has averaged between thirty-five and forty million people watching per year.
01/02/2013 - 11:46am
Overall, 2012 was notable for the movie industry in a number of ways: Two major studios celebrated their 100th anniversaries; six blockbusters of the past were re-released in 3D or IMAX; three new movies joined the billion-dollar club.
07/16/2012 - 10:40am
It is not an exaggeration to say that Batman is one of the most popular, if not the most popular, comic book superheroes. Almost since his debut in 1939, the character has been a staple of popular culture both in America and around the world.
07/06/2012 - 12:00pm
In a flash note published earlier on Friday, Sterne Agee reiterated its Buy rating and $50.00 price target on Navistar International (NYSE: NAV). Sterne Agee went on to say “We believe Navistar's streamlined cost base, revised product portfolio, stable defense segment, and multiple high-growth joint ventures will likely enable the company to deliver
07/06/2012 - 11:17am
In a report published Friday morning, Oppenheimer Holdings moved its rating on ShangPharma Corporation (NYSE: SHP) from Outperform to Not Rated, as well as removing its $14.00 price target, on the company CEO's proposal letter to acquire all outstanding
07/06/2012 - 11:11am
In a quick note published Friday morning, Wedbush Securities reiterated its Outperform rating and $48.00 price target on eBay Inc. (NASDAQ: EBAY). In the report, Wedbush stated, “We believe EBAY will outperform as it transforms into a payments-driven company and garners V/MA-like multiples.
07/06/2012 - 11:05am
In a report published earlier today, J.P. Morgan reiterated its Overweight rating on Ambow Education Holding Ltd. (NYSE: AMBO), but lowered its price target from $11.10 to $9.00. In the report, J.P.
07/06/2012 - 11:00am
In a company update published earlier today, Dawson James Securities reiterated its Buy rating on Galectin Therapeutics (NASDAQ: GALT), but lowered its price target to $3.00. Dawson James went on to say, “Galectin Therapeutics shares have declined this year, following a delay in product approvals in International jurisdictions and a reverse stock
07/06/2012 - 10:50am
In a company update published earlier today, Dahlman Rose & Company, LLC reiterated its Buy rating and $50.00 price target on Golar LNG Limited (NASDAQ: GLNG). Dahlman Rose went on to state in the report that, “Golar has been awarded a 15-20 year FSRU contract off the coast of Chile, the country's first.
06/25/2012 - 11:22am
"You think it is over, but the games have just begun." So said Tobin Bell as the Jigsaw Killer from the "Saw" franchise. Much the same could be said for Lions Gate Entertainment (NYSE: LGF), the studio that for a long time was most notable for bringing the original "Saw" and its six sequels to the big screen.

Get Benzinga's News Delivered Free